amcure Announces First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results.
Please read the press release for more information.
amcure Announces First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results.
Please read the press release for more information.
© 2019 amcure GmbH | Imprint/Impressum | Privacy Policy/Datenschutzerklärung
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.